Pembrolizumab improves OS in firstline treatment for unresectable advanced pleural mesothelioma
Pembrolizumab improves OS in firstline treatment for unresectable advanced pleural mesothelioma
Pembro plus chemo followed by resection and adjuvant pembro improves on standard of care for early NSCLC
Tackling low-volumes of clinical trials in Africa
The HypoAfrica study and AC3T research partnerships at NLCC
Achieving health equity in cancer care in the Philippines
Tusamitamab ravtansine combined with SoC shows encouraging anti-tumour activity for patients with nonsquamous NSCLC
Pegargiminase-pemetrexed-platinum triplet therapy prolongs survival in non-epithelioid pleural mesothelioma
To avoid unnecessary second surgery in differentiated thyroid cancer
Key practices for handling difficult conversations in cancer care
Choosing wisely in complementary treatment for cancer in the Philippines
Indications for the appropriate use of a PET-CT scan for common cancers
A multidisciplinary team approach to cancer care in the Philippines